AIQ Solutions captures intelligence from standard format imaging data, delivering guidance for the treatment of patients.
AIQ’s technology is driven by artificial intelligence and designed to improve the understanding of patient treatment response for complex diseases. We do this by capturing and quantifying patient imaging data.
AIQ's technology is modality agnostic. We’re able to use data from PET, CT and other types of scans to provide oncologists, radiologists and researchers with multiple layers of information that are relevant for evaluating the effectiveness of prescribed patient treatments.
The first step is for clinical sites to upload the patient’s anatomic and molecular scans to AIQ’s technology platform. The AIQ algorithms then use artificial intelligence and other advanced analytics to do the following:
Localize and identify all the individual lesions based on molecular imaging agent uptake in combination with anatomical CT information. AIQ’s proprietary algorithms adjust the threshold standardized uptake values [SUV] based on disease type and physiological location.
Quantify the disease burden associated with each individual lesion based on molecular imaging agent uptake values.
Automatically correct for changes in patient position among scans from different time points using an articulated registration technique that employs a rigid registration of individual skeletal bones from CT combined with data of lesions from PET/CT.
Match lesions from successive scans to establish longitudinal correspondence of the lesions and to assess response.
Calculate a comprehensive set of treatment response metrics consisting of different SUV measures.
Export results in different formats, including a treatment planning report for the oncologist and an interactive review application for the radiologist/nuclear medicine physician.
For every patient that has at least two imaging scans, captured at a specific period of time, for a specific treatment, AIQ provides a Treatment Response Report. AIQ’s TRA provides treatment response information on each individual lesion, including what is driving disease progression, so that better treatment decisions can be achieved.
Learn more about AIQ’s Treatment Response Assessments:
Quantitative response metrics based on changes in disease burden and volume for every lesion at different points in time.
Response analysis of every lesion over time including:
- Individual lesion location with corresponding response status
- Change in number of lesions
- 3D rendering of patient
AIQ is a medical device technology that is unique in it's capabilities to use AI in identifying and helping to assess treatment. The chart on the right shows how AIQ compares to other common practices.
This document contains claims that have not been reviewed by the FDA. For information about applications in commercial distribution for patient management, see www.aiq-solutions.com/customers/hospitals